 preval incid human immunodefici viru patient long-term hemodialysi cooper dialysi studi group purpos purpos voluntari multicent studi preval incid human immunodefici viru hiv infect risk nosocomi transmiss hiv hemodialysi patient unit patient method june epidemiolog data risk factor inform serum hiv antibodi long-term hemodialysi patient entri studi year initi data specimen patient dialysi center state entri posit equivoc enzym immunoassay posit western blot overal seropreval seropreval patient center area high cumul incid acquir immunodefici syndrom case person patient area versu dialysi record western blot-posit patient transfus seroposit patient like transfus seroneg patient versu confidenti risk factor questionnair patient seroposit patient question needl inject drug patient seroposit patient like needl seroneg patient versu year follow-up data patient neg patient underw dialysi center seroposit patient none seroneg patient incid rate upper limit confid interv case possibl nosocomi transmiss conclus result use long-stand infect control precaut effect risk transmiss hiv hemodialysi set